|
The ten top killers of Americans (in the order of frequency) include heart disease, cancer, stroke, accidents, pneumonia,
diabetes, cirrhosis, arteriosclerosis, suicides, and infant death. All but accidents, pneumonia, suicides, and infant death
have an underlying connection to reduced blood circulation. More than 90 percent of Americans live in jeopardy of having a
serious illness relating to the circulatory system.
The human and financial cost of cardiovascular disease in the U.S. is astronomical. Every year, approximately 1.5 million
Americans have a heart attack, 300,000 of whom die before receiving medical attention. The treatment of cardiovascular disease
rings up a total of $100 billion dollars annually-$200,000 spent every minute. Coronary artery bypass surgery (bypassing the
blocked heart artery with grafted leg artery, average cost $44,000) is the most frequently prescribed surgical procedure for
heart disease, costing $10 billion per year. Numerous leading medical doctors and authorities have stated that coronary bypass
surgery is over prescribed and often unnecessary. Nearly 20,000 people die every year as a result of bypass surgery or angioplasty
(ballooning of the occluded artery, average cost $21,000).
Intravenous chelation is far safer, much less expensive, and less invasive. Proven effective in circulatory disorders,
its benefits for cardiovascular patients are clear. IV chelation does pose some risks, however. Although nontoxic, EDTA produces
side effects in some people. These include burning, redness and swelling at the injection site, fever, hypotension (low blood
pressure), joint pain, skin outbreaks or rashes, upset stomach, and, rarely, irritation of the kidneys and liver. These effects
are RARELY noted by the patients and generally occur if the IV is poorly placed or the flow rate of the solution is too rapid.
We spend a significant amount of time with our patients and monitor them throughout the procedure. Our experience has been
very positive with none of the above side effects.
In addition to the effectiveness of IV EDTA chelation therapy in treating cardiovascular disease and heavy metal toxicity,
research has documented its benefits for aneurysm, Alzheimer's disease and senile dementia, arthritis, autoimmune conditions,
cancer, cataracts, diabetes, emphysema, gallbladder stones, hypertension, kidney stones, Lou Gehrig's disease, osteoporosis,
Parkinson's disease, scleroderma, stroke, varicose veins, venomous snake bite, and other conditions involving an interruption
in blood flow and diminished oxygen delivery.
Some cardiologists who understand the benefits of intravenous EDTA chelation do not recommend its use with patients who
are debilitated, emaciated, have weak or diseased kidneys, or advanced cardiovascular disease (end stage). They believe the
sudden, massive infusion of EDTA puts too much stress on the kidneys, liver and detoxification pathways in these patients
and could be harmful or even dangerous. Other doctors and medical researchers disagree, contending that "transient kidney
malfunction" is a normal physiological adaptation occurring during the passage of toxic products (chelated metals and
chemicals) through the kidneys, and that properly administered IV chelation will not cause kidney damage. My experience has
been consistently that by tailoring the proper dose and the flow rate even weak and debilitated patients can be safely treated.
A common misconception about chelation is that it lowers the levels of calcium in the bones and teeth as the body draws
calcium from them to replace the calcium drawn from the blood by the chelation process. On the contrary, the calcium to restore
blood levels is drawn from places in the body where calcium has built up unnaturally, as in arterial plaques (which contribute
to clogged arteries), calcified bursae (a source of bursitis), arthritic joints, and kidney stones.
Further, Garry Gordon, M.D., D.O., co-founder of the American College for Advancement in Medicine (ACAM) and a pioneer
in chelation therapy, states, "If calcium levels start to drop, the parathyroid glands kick in and start secreting parathormone
which 'steals' back enough calcium from the EDTA (and other) chelates to keep the heart beating normally (serum calcium must
stay at a constant level for normal heart function) and to activate cells called osteoblasts, which strengthen and rebuild
bone. The more chelation we give people, the less osteoporosis they have and the less age-related calcium accumulation [arterial
wall plaques] there is in the blood vessels."
There is no limit to the amount of IV EDTA chelation a person can be given and the peak beneficial effects last up to
two months after treatment. IV chelation is safe for children as well as adults. People over 90 years old have enjoyed the
benefits of chelation and more than 200,000 children in the U.S. have undergone IV chelation as treatment for lead poisoning.
There has been a large body of scientific information published on Chelation therapy. The following list of sites will
give you an overview of the literature and some of the opinions of the leading physicians in this field.
A NEW THEORETICAL MECHANISM OF ACTION OF EDTA CHELATION THERAPY
The History of EDTA
Number of good articles for review of Chelation subjects
Physician Group Backs New NIH Chelation Therapy Study For Heart Disease For information regarding the current
30 Million dollar TACT study of chelation therapy, by the National Institute of Health.
Some of the scientific findings include:
- Stabilization of arterial intracellular membranes and maintenance of the electrical charge of platelets in the blood,
reducing blood clumping (aggregation) and preventing blood clots.
- Marked improvement in nearly 100% of 2,870 studied patients with peripheral vascular disease
- Normalization of half of treated cardiac arrhythmias
- Reductions of cerebrovascular occlusion and improved cognitive function in people with memory and concentration deficits
and improved visual acuity (when problems are caused by arterial blockage)
- Improved myocarditis due to lead poisoning.
- Reduction of blood fat levels and improved capillary blood flow. o Increased peripheral blood flow to the extremities.
-Improved compliance of vascular tissues; decalcification of elastic tissues resulting in improved elasticity and resilience.
-Improved red blood cell membrane flexibility and permeability to potassium
-Decreased blood pressure levels, as a result of excretion of cadmium from renal tissues, diminished peripheral resistance,
improved blood vessel resilience and pliability, decreased vascular spasm, and improved magnesium uptake.
Intravenous chelation has two drawbacks, however. Although much safer and less expensive than coronary bypass surgery
or angioplasty, it is still relatively expensive as no insurance company will reimburse for the proceedure ($125.00 dollars per visit) and not widely available, as there are comparatively
few experienced physicians certified in IV chelation therapy.
Dr. Kadish is certified and a member on the committee of the American College for Advancement in Medicine, (ACAM) involved in the board certification process for Chelation therapy.
Additionally at the Center, we have non-invasive testing methods to evaluate your progress in addition to the subjective feelings
of well being that many of the patients experience.
|
